Table 2.
Antihypertensive medication use
| Description | Total follow-up (months) | Mean follow-up per subject (months±SD) | Unique subjects |
|---|---|---|---|
| Total (all) | 133,530 | 87.4 (22.6) | 1,527 |
| Number of antihypertensive medications | |||
| One | 24,972 | 20.5 (21.3) | 1,218 |
| Two | 31,580 | 24.8 (20.1) | 1,271 |
| Three | 26,886 | 25.3 (19.2) | 1,064 |
| Four | 15,680 | 22.1 (17.9) | 711 |
| Five | 6,370 | 17 (15.7) | 375 |
| Six | 1,335 | 12 (13) | 111 |
| Seven | 159 | 8.8 (6.3) | 18 |
| Monotherapy (most common occurrences) | |||
| Angiotensin converting enzyme inhibitor | 8,673 | 15.7 (19.8) | 552 |
| Beta-adrenergic receptor blocker | 5,017 | 13.4 (18.3) | 374 |
| Diuretic | 3,820 | 10.5 (14.3) | 363 |
| Calcium channel blocker | 3,242 | 11.5 (15.9) | 281 |
| Angiotensin receptor blocker | 852 | 11.5 (14.6) | 74 |
| Dual therapy (most common occurrences) | |||
| Angiotensin converting enzyme inhibitor and diuretic | 33,389 | 39.3 (28.5) | 850 |
| Angiotensin converting enzyme inhibitor and beta-adrenergic receptor blocker | 27,608 | 37.3 (27.8) | 740 |
| Diuretic and beta-adrenergic receptor blocker | 27,686 | 35.7 (26.7) | 776 |
| Diuretic and calcium channel blocker | 23,022 | 36.7 (27.1) | 627 |
| Angiotensin converting enzyme inhibitor and calcium channel blocker | 22,006 | 35.4 (26.7) | 621 |